Search for: "Sterling v. Weinstein" Results 1 - 14 of 14
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
14 Jul 2023, 6:30 am
Stronski, Skadden, Arps, Slate, Meagher & Flom LLP, on Tuesday, July 11, 2023 Tags: Board composition, directors, Mergers & acquisitions, SEC enforcement, Shareholder activism, universal proxy rule X Corp. v. [read post]
14 Jul 2023, 6:30 am
Stronski, Skadden, Arps, Slate, Meagher & Flom LLP, on Tuesday, July 11, 2023 Tags: Board composition, directors, Mergers & acquisitions, SEC enforcement, Shareholder activism, universal proxy rule X Corp. v. [read post]
2 Dec 2022, 6:30 am
Posted by the Harvard Law School Forum on Corporate Governance, on Friday, December 2, 2022 Editor's Note: This roundup contains a collection of the posts published on the Forum during the week of November 25-December 1, 2022 Lessons from the Chancery Court Decision in P3 Health Group Posted by Gail Weinstein, Steven J. [read post]
2 Dec 2022, 6:30 am
Posted by the Harvard Law School Forum on Corporate Governance, on Friday, December 2, 2022 Editor's Note: This roundup contains a collection of the posts published on the Forum during the week of November 25-December 1, 2022 Lessons from the Chancery Court Decision in P3 Health Group Posted by Gail Weinstein, Steven J. [read post]
3 Dec 2021, 6:06 am
, Proxy advisors, Proxy voting, Say on climate, Shareholder voting Important Earnout/Milestone Drafting Points Arising from Recent Pacira and Shire Decisions Posted by Gail Weinstein, Brian T. [read post]
31 Jan 2016, 1:12 am by Bill Otis
 Then, as now, he concealed the defendant's name (calling the case "US v. [read post]
5 Jul 2013, 5:00 am by Bexis
Sterling Drug, Inc., 795 P.2d 915, 931 (Kan. 1990) (“compliance with FDA rules and regulations creates only a rebuttable presumption that the warnings are adequate”); MacDonald v. [read post]